2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Neoplasms, Advanced Solid: new trials by email Literature Review of Neoplasms, Advanced Solid trials Research Report on Neoplasms, Advanced Solid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors TAK-931 PIC, TAK-931 Tablet, Esomeprazole - Neoplasms, Advanced Solid | Phase 1 | Completed | Millennium Pharmaceuticals, Inc. | 20 | 2019-03-28 | 2020-12-29 |
| A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors Trebananib 3 mg/kg, Trebananib 10 mg/kg, Trebananib 30 mg/kg - Neoplasms, Advanced Solid | Phase 1 | Completed | Takeda | 18 | 2009-06-01 | 2015-09-22 |
Neoplasms (2)
Esomeprazole (1) · simurosertib (1) · trebananib (1)
Millennium Pharmaceuticals, Inc. (1) · Takeda (1)
Netherlands (1)
2017 (1)